Twenty-eight states restrict access to mifepristone, according to the organization, four of which prohibit the mailing of abortion pills to patients. The filing from the Trump administration is ...

The Department of Justice on Monday said a lawsuit against the Food and Drug Administration seeking to sharply restrict the abortion pill mifepristone should be dismissed, continuing the position ...

In a court brief filed April 5, the Trump administration did not debate the legality of the pill or defend its use in almost two-thirds of pregnancy terminations in the U.S. Rather, the Justice ...

Younger women with asthma who take the mini pill may be at a higher risk of potentially life-threatening asthma attacks, a new study suggests. Researchers from Imperial College London found that ...

The pill can be taken up to "70 days since the first day of their last menstrual period," according to the FDA. The exact number of women who have undergone a mifepristone abortion since the FDA ...

Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a pill. The Danish multinational company currently sells the medicine ...

President Donald Trump’s Justice Department is slated to defend regulations from the Food and Drug Administration that allow abortion pills to be sold online and shipped to patients in the mail.

Thousands of women who take the mini pill may be at higher risk of potentially life-threatening asthma attacks, concerning research today suggested. British scientists, who tracked more than ...

Women who take a certain type of contraceptive pill are at 40% higher risk of having an asthma attack, a study has shown. Experts say the research could help us understand why asthma tends to be ...

About two-thirds of abortions in the U.S. are medication abortions, which most commonly involve the pills mifepristone and misoprostol. Both were approved by the FDA 25 years ago after rigorous ...

The abortion pill mifepristone "is not safe and effective," argue the authors of a new study that uses insurance claim data to examine adverse reactions to the pill. They claim to have found a ...

The Danish drugmaker – which has its U.S. headquarters in Plainsboro – seeks regulatory approval for a once-a-day 25 milligram pill form of the semaglutide for chronic weight management ...